|
作者｜Penny BS 校稿｜Haoran PHD 編審｜Xinyin PHD, RD 設(shè)計(jì)｜Fay 點(diǎn)擊查看高清圖文 ▼ ■■
■■ 參考文獻(xiàn) [1] Fuchs M, Yuan C, Sato K et al. Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance). Annals of Oncology. 2017;28(6):1359-1367. doi:10.1093/annonc/mdx109. [2] Chen S, Bu D, Ma Y et al. H19 Overexpression Induces Resistance to 1,25(OH)2D3 by Targeting VDR Through miR-675-5p in Colon Cancer Cells. Neoplasia. 2017;19(3):226-236. doi:10.1016/j.neo.2016.10.007. [3] Tavera-Mendoza L, Westerling T, Libby E et al. Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells. Proceedings of the National Academy of Sciences. 2017;114(11):E2186-E2194. doi:10.1073/pnas.1615015114. [4] Li M, Li L, Zhang L et al. Vitamin D and Cancer Stem Cells in the Gastrointestinal Tract. Current Medicinal Chemistry. 2017;24(9):918-927. doi:10.2174/0929867324666170214110633. [5] Li M, Li L, Zhang L et al. 1,25-Dihydroxyvitamin D 3 suppresses gastric cancer cell growth through VDR- and mutant p53-mediated induction of p21. Life Sciences. 2017;179:88-97. doi:10.1016/j.lfs.2017.04.021. [6] Feldman D, Krishnan A, Swami S, Giovannucci E, Feldman B. The role of vitamin D in reducing cancer risk and progression. Nature Reviews Cancer. 2014;14(5):342-357. doi:10.1038/nrc3691. [7] Duffy M, Murray A, Synnott N, O’Donovan N, Crown J. Vitamin D analogues: Potential use in cancer treatment. Critical Reviews in Oncology/Hematology. 2017;112:190-197. doi:10.1016/j.critrevonc.2017.02.015. [8] Mondul A, Weinstein S, Layne T, Albanes D. Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges. Epidemiologic Reviews. 2017:1-21. doi:10.1093/epirev/mxx005. [9] 高等院校老年服務(wù)與管理專(zhuān)業(yè)規(guī)劃教材《老年人營(yíng)養(yǎng)與膳食》吳育紅編著，郭紅衛(wèi)主審，浙江大學(xué)出版社 |
|
|
